Treating Fairly Research Award

The ASH Treating Fairly Research Award program was established in response to concerns about recent shifts in federal funding priorities, which have reduced support for research focused on hematologic diseases and disorders that disproportionately affect specific communities. ASH has long recognized the importance of addressing these disparities and remains committed to advancing equitable and fair outcomes for all patients. Securing funding for research that supports this mission is essential.

An Unprecedented Investment

Since 2025, ASH has more than doubled its level of support for awards, career development opportunities, and mentorship programs as part of the #Fight4Hematology campaign. This unprecedented investment of $25 million to date into hematology research awards – above and beyond ASH’s traditional funding levels – brings ASH’s total award funding across 2025-2026 to nearly $50 million, supporting 3,500+ awards.

Key Information

Program Benefits

The Treating Fairly Research Award provides $200,000 in funding, which may be used over a period of 1, 2, or 3 years depending on the recipient’s preference. It is available to researchers who hold a PhD, an MD/DO, or an MD/DO, PhD who are no longer eligible for the ASH AMFDP and ASH Scholar Awards.
See Additional Benefit Information

Eligibility Requirements

Applicants must be ASH members serving as Principal Investigators at eligible institutions, be U.S., Mexico, or Canadian citizens (or visa/PR holders conducting research in the U.S., Mexico, or Canada), have no more than $500,000 in other resources, and meet all criteria by the application deadline.
See Additional Eligibility Requirements

Application Process and Required Materials

Applications must be submitted through the ASH online awards system and include all required forms, statements, budget details, biographical sketch, project proposal, ethical certification, and resource information.
See Additional Information on Required Materials

Evaluation and Selection

Award applications are assessed based on the scientific merit and qualifications of the applicant. To maintain programmatic balance, a maximum of two awards will be granted per medical school. Individuals selected to receive this award will be notified in March 2026 with the award commencing upon notification.
See Evaluation Criteria

Key Dates

Application Available  August 15, 2026
Application Deadline  November 15, 2026
Award Notification  January 2027
Award ActivationUpon Notification

Award Recipients

View Treating Fairly Award Recipients

Have a Question?

For general questions about the application, page or contact awards@hematology.org.

Stay Informed

Never miss an important deadline—sign up to receive email updates about ASH awards and training programs.